< 1 minute read
Sep. 17, 2021
Compound (P)-14: a PI3K beta-isoform selective lipid kinase inhibitor
“Compound (P)-14″
atropisomeric PI3K beta-selective inhibitor off-target tox. in higher species, discontinued from rational design of known starting point J. Med. Chem., Apr. 15, 2020 Gilead Sciences, Seattle, WA + Foster
Loading...
